483 related articles for article (PubMed ID: 29879995)
1. Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer cases.
Hamdi Y; Boujemaa M; Ben Rekaya M; Ben Hamda C; Mighri N; El Benna H; Mejri N; Labidi S; Daoud N; Naouali C; Messaoud O; Chargui M; Ghedira K; Boubaker MS; Mrad R; Boussen H; Abdelhak S;
J Transl Med; 2018 Jun; 16(1):158. PubMed ID: 29879995
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel candidate genes by exome sequencing in Tunisian familial male breast cancer patients.
Ben Kridis-Rejeb W; Ben Ayed-Guerfali D; Ammous-Boukhris N; Ayadi W; Kifagi C; Charfi S; Saguem I; Sellami-Boudawara T; Daoud J; Khanfir A; Mokdad-Gargouri R
Mol Biol Rep; 2020 Sep; 47(9):6507-6516. PubMed ID: 32901360
[TBL] [Abstract][Full Text] [Related]
4. The Identification by Exome Sequencing of Candidate Genes in
BenAyed-Guerfali D; Kifagi C; BenKridis-Rejeb W; Ammous-Boukhris N; Ayedi W; Khanfir A; Daoud J; Mokdad-Gargouri R
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893033
[TBL] [Abstract][Full Text] [Related]
5. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
Silvestri V; Zelli V; Valentini V; Rizzolo P; Navazio AS; Coppa A; Agata S; Oliani C; Barana D; Castrignanò T; Viel A; Russo A; Tibiletti MG; Zanna I; Masala G; Cortesi L; Manoukian S; Azzollini J; Peissel B; Bonanni B; Peterlongo P; Radice P; Palli D; Giannini G; Chillemi G; Montagna M; Ottini L
Cancer; 2017 Jan; 123(2):210-218. PubMed ID: 27648926
[TBL] [Abstract][Full Text] [Related]
6. Whole-exome sequencing of Finnish hereditary breast cancer families.
Määttä K; Rantapero T; Lindström A; Nykter M; Kankuri-Tammilehto M; Laasanen SL; Schleutker J
Eur J Hum Genet; 2016 Jan; 25(1):85-93. PubMed ID: 27782108
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing in familial breast cancer patients from Lebanon.
Jalkh N; Chouery E; Haidar Z; Khater C; Atallah D; Ali H; Marafie MJ; Al-Mulla MR; Al-Mulla F; Megarbane A
BMC Med Genomics; 2017 Feb; 10(1):8. PubMed ID: 28202063
[TBL] [Abstract][Full Text] [Related]
8. Whole-exome sequencing of familial cases of multiple morphological abnormalities of the sperm flagella (MMAF) reveals new DNAH1 mutations.
Amiri-Yekta A; Coutton C; Kherraf ZE; Karaouzène T; Le Tanno P; Sanati MH; Sabbaghian M; Almadani N; Sadighi Gilani MA; Hosseini SH; Bahrami S; Daneshipour A; Bini M; Arnoult C; Colombo R; Gourabi H; Ray PF
Hum Reprod; 2016 Dec; 31(12):2872-2880. PubMed ID: 27798045
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.
ElBiad O; Laraqui A; El Boukhrissi F; Mounjid C; Lamsisi M; Bajjou T; Elannaz H; Lahlou AI; Kouach J; Benchekroune K; Oukabli M; Chahdi H; Ennaji MM; Tanz R; Sbitti Y; Ichou M; Ennibi K; Badaoui B; Sekhsokh Y
BMC Cancer; 2022 Feb; 22(1):208. PubMed ID: 35216584
[TBL] [Abstract][Full Text] [Related]
10. Sequencing for germline mutations in Swedish breast cancer families reveals novel breast cancer risk genes.
Helgadottir HT; Thutkawkorapin J; Lagerstedt-Robinson K; Lindblom A
Sci Rep; 2021 Jul; 11(1):14737. PubMed ID: 34282249
[TBL] [Abstract][Full Text] [Related]
11. Identification of Novel
Mighri N; Hamdi Y; Boujemaa M; Othman H; Ben Nasr S; El Benna H; Mejri N; Labidi S; Ayari J; Jaidene O; Bouaziz H; Ben Rekaya M; M'rad R; Haddaoui A; Rahal K; Boussen H; Boubaker S; Abdelhak S
Front Genet; 2020; 11():552971. PubMed ID: 33240314
[TBL] [Abstract][Full Text] [Related]
12. Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39.
Kuligina ES; Sokolenko AP; Bizin IV; Romanko AA; Zagorodnev KA; Anisimova MO; Krylova DD; Anisimova EI; Mantseva MA; Varma AK; Hasan SK; Ni VI; Koloskov AV; Suspitsin EN; Venina AR; Aleksakhina SN; Sokolova TN; Milanović AM; Schürmann P; Prokofyeva DS; Bermisheva MA; Khusnutdinova EK; Bogdanova N; Dörk T; Imyanitov EN
Breast Cancer Res Treat; 2020 Feb; 179(3):731-742. PubMed ID: 31754952
[TBL] [Abstract][Full Text] [Related]
13. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
[TBL] [Abstract][Full Text] [Related]
14. Using linkage studies combined with whole-exome sequencing to identify novel candidate genes for familial colorectal cancer.
Toma C; Díaz-Gay M; Franch-Expósito S; Arnau-Collell C; Overs B; Muñoz J; Bonjoch L; Soares de Lima Y; Ocaña T; Cuatrecasas M; Castells A; Bujanda L; Balaguer F; Cubiella J; Caldés T; Fullerton JM; Castellví-Bel S
Int J Cancer; 2020 Mar; 146(6):1568-1577. PubMed ID: 31525256
[TBL] [Abstract][Full Text] [Related]
15. Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia.
Ben Ayed-Guerfali D; Ben Kridis-Rejab W; Ammous-Boukhris N; Ayadi W; Charfi S; Khanfir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
J Transl Med; 2021 Mar; 19(1):108. PubMed ID: 33726785
[TBL] [Abstract][Full Text] [Related]
16. Identification of
Hamdi Y; Boujemaa M; Mighri N; Mejri N; Jaidane O; Ben Nasr S; Bouaziz H; Hassouna JB; Zribi A; Berrazaga Y; Rachdi H; Daoud N; El Benna H; Labidi S; Haddaoui A; Rahal K; Benna F; Boussen H; Abdelhak S; Boubaker S
Front Genet; 2021; 12():674990. PubMed ID: 34456966
[No Abstract] [Full Text] [Related]
17. Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility.
Lee NY; Hum M; Amali AA; Lim WK; Wong M; Myint MK; Tay RJ; Ong PY; Samol J; Lim CW; Ang P; Tan MH; Lee SC; Lee ASG
Hum Genomics; 2022 Nov; 16(1):61. PubMed ID: 36424660
[TBL] [Abstract][Full Text] [Related]
18. Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer.
Wen H; Kim YC; Snyder C; Xiao F; Fleissner EA; Becirovic D; Luo J; Downs B; Sherman S; Cowan KH; Lynch HT; Wang SM
BMC Cancer; 2014 Jun; 14():470. PubMed ID: 24969172
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
20. Unique Features of Germline Variation in Five Egyptian Familial Breast Cancer Families Revealed by Exome Sequencing.
Kim YC; Soliman AS; Cui J; Ramadan M; Hablas A; Abouelhoda M; Hussien N; Ahmed O; Zekri AN; Seifeldin IA; Wang SM
PLoS One; 2017; 12(1):e0167581. PubMed ID: 28076423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
